Evidence map›Paper›PMID 34443952›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Application of Molecular Vapour Deposited Al

Muhammad Munem Ali, Jacob John Mitchell, Gregory Burwell, Klaudia Rejnhard, Cerys Anne Jenkins, Ehsaneh Daghigh Ahmadi, Sanjiv Sharma, Owen James Guy

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Muhammad Munem AliCentre for NanoHealth, College of Engineering, Swansea University, Swansea SA2 8PP, UK.ORCID 0000-0001-9151-4194
Jacob John MitchellCentre for NanoHealth, College of Engineering, Swansea University, Swansea SA2 8PP, UK.
Gregory BurwellDepartment of Physics, College of Science, Swansea University, Swansea SA2 8PP, UK.
Klaudia RejnhardDepartment of Physics, College of Science, Swansea University, Swansea SA2 8PP, UK.
Cerys Anne JenkinsSchool of Medicine, Swansea University, Swansea SA2 8PP, UK.ORCID 0000-0002-3719-7463
Ehsaneh Daghigh AhmadiCentre for NanoHealth, College of Engineering, Swansea University, Swansea SA2 8PP, UK.
Sanjiv SharmaFaculty of Science and Engineering, Bay Campus, Swansea University, Swansea SA1 8EN, UK.ORCID 0000-0003-3828-737X
Owen James GuyCentre for NanoHealth, College of Engineering, Swansea University, Swansea SA2 8PP, UK.ORCID 0000-0002-6449-4033

Funding

Newton Fund-China-UK Research and Innovation Bridges Competition 2015 102877
6 · The paper itself

Abstract

Graphene-based point-of-care (PoC) and chemical sensors can be fabricated using photolithographic processes at wafer-scale. However, these approaches are known to leave polymer residues on the graphene surface, which are difficult to remove completely. In addition, graphene growth and transfer processes can introduce defects into the graphene layer. Both defects and resist contamination can affect the homogeneity of graphene-based PoC sensors, leading to inconsistent device performance and unreliable sensing. Sensor reliability is also affected by the harsh chemical environments used for chemical functionalisation of graphene PoC sensors, which can degrade parts of the sensor device. Therefore, a reliable, wafer-scale method of passivation, which isolates the graphene from the rest of the device, protecting the less robust device features from any aggressive chemicals, must be devised. This work covers the application of molecular vapour deposition technology to create a dielectric passivation film that protects graphene-based biosensing devices from harsh chemicals. We utilise a previously reported "healing effect" of Al

Indexed as

aluminium oxidebiosensorsgraphenemolecular vapour depositionpassivation

Identifiers

PMID34443952
PMCPMC8398646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.